Ludger Roedder
President at Adare Pharmaceuticals SAS
Profile
Ludger Roedder is currently a member of the Council for Responsible Nutrition, a member of the American Feed Industry Association, and the President of Adare Pharmaceuticals SAS.
He was previously the Chief Business Officer at BRAIN Biotech AG.
Mr. Roedder holds a Master's in Business Administration from Fairleigh Dickinson University.
Ludger Roedder active positions
| Companies | Position | Start |
|---|---|---|
| American Feed Industry Association | Corporate Officer/Principal | - |
| Council for Responsible Nutrition | Corporate Officer/Principal | - |
Adare Pharmaceuticals SAS
 Adare Pharmaceuticals SAS Pharmaceuticals: MajorHealth Technology Adare Pharmaceuticals SAS offers effective abuse deterrence testing services to help develop formulations that cannot be misused by consumers. The private company is based in Houdan, France. The French company is a technology-driven cdmo providing product development through commercial manufacturing expertise focused on oral dosage forms for the pharmaceutical industry. Adare's technologies provide oral dose forms with taste masking and a modified release profile, among other capabilities. It was founded in 2015, and the CEOs are Gilles Chauviere, Isabelle de Azevedo, Michael Ryan, and Thomas Sellig. | President | 2021-12-02 |
Former positions of Ludger Roedder
| Companies | Position | End |
|---|---|---|
| BRAIN BIOTECH AG | Corporate Officer/Principal | 2020-07-06 |
Training of Ludger Roedder
| Fairleigh Dickinson University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BRAIN BIOTECH AG | Health Technology |
| Private companies | 3 |
|---|---|
| American Feed Industry Association | |
| Council for Responsible Nutrition | |
Adare Pharmaceuticals SAS
Adare Pharmaceuticals SAS Pharmaceuticals: MajorHealth Technology Adare Pharmaceuticals SAS offers effective abuse deterrence testing services to help develop formulations that cannot be misused by consumers. The private company is based in Houdan, France. The French company is a technology-driven cdmo providing product development through commercial manufacturing expertise focused on oral dosage forms for the pharmaceutical industry. Adare's technologies provide oral dose forms with taste masking and a modified release profile, among other capabilities. It was founded in 2015, and the CEOs are Gilles Chauviere, Isabelle de Azevedo, Michael Ryan, and Thomas Sellig. | Health Technology |
- Stock Market
- Insiders
- Ludger Roedder
